Lilly profit climbs 18 percent after one-time expenses
The Indianapolis-based drugmaker beat Wall Street expectations by 2 cents a share—performance it attributed to brisk sales of new products.
John Russell
Articles
IU, Regenstrief, Eskenazi team up to demystify electronic health records for med students
Physicians use electronic health records all day long. How will medical students learn about them? The AMA is rolling out a new program developed in Indianapolis.
Local life sciences, pharma consultancy acquired by German firm
Safis Solutions LLC, a 15-year-old Indianapolis consulting firm that helps life science companies move their products through the government regulatory process, has been acquired by PharmaLex, the companies announced Monday.
Community makes latest push into oncology with $60M cancer center
Community Health Network’s new Cancer Center North, which will have its grand opening Saturday is designed to lift patients’ spirits as much as kill cancer cells.
How Dow won fight to save key product
When Dow AgroSciences needed to battle a proposed federal ban on one of its most important products, it drafted an army—its farmers.
New hospital to rewrite rules of psychiatric care
Indiana’s newest state psychiatric hospital, which is about to rise on the campus of Community Hospital East, is designed to fill a critical gap in the state’s mental health landscape.
Wall Street punishes Lilly for latest drug setback; analysts grasp for answers
News that federal regulators rejected Lilly’s drug for arthritis sent the stock tumbling more than 5 percent Monday, and sent surprised analysts searching for answers.
Fairbanks Foundation doles out $376,000 to train army of addiction specialists
The money, provided to the workforce initiative Ascend Indiana, will train up to 50 specialists a year targeting Indiana's growing opioid epidemic.
A list that should make Hoosier doctors smile
For the third year in a row, Indiana ranks among the top states in average physician compensation.
FDA issues warning to local doctor for breaking protocol on drug trial
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Marian medical school’s first graduates could fill primary-care dearth
Almost half of graduating students in Marian University’s novice College of Osteopathic Medicine are choosing to serve residencies in family medicine.
Insurance giant buying American Health Network doctor group
In the latest sign of health care consolidation, Indiana’s largest independent physician group has agreed to be acquired by the nation’s largest health insurer for $184 million.
FOCUS: Biosciences institute’s chief scientific officer aims to foster commercialization
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Local Roche units sue pharmacies over alleged test-strip scheme
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
Indiana enrollment in health exchanges plunges 11 percent
As Republicans pushed to end the Affordable Care Act, nearly 22,000 fewer Hoosiers bought health coverage on the exchanges, a decline some say could hurt hospitals.
UPDATE: Lilly to invest $85M in Indy as part of diabetes expansion
The expansion at the Lilly Technology Center southwest of downtown is part of an $850 million investment the company is making this year in its U.S. research labs, manufacturing plants and other operations.
Orthopedics business makes local distribution move, preserving 100 jobs
Breg Inc. will continue to supply thousands of orthopedic surgeons from operations in Indianapolis after relocating to a facility near the airport.
Lilly CEO Ricks stands to make about $12M in first year at helm
Dave Ricks joined Lilly in 1996 and most recently served as president of Lilly Bio-Medicines. He took over as president and CEO on Jan. 1.
Advanced nurses in huge demand
In hospitals and clinics around Indiana, specialized nurses with advanced degrees and extensive training are booming in numbers.
Eli Lilly chasing psoriasis jackpot with Taltz
Taltz, which hit the market last year, is taking on an armful of older treatments, including creams, lotions, pills and injectables, such as Amgen’s Enbrel and AbbVie’s Humira.